{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:03:02Z","timestamp":1780056182975,"version":"3.54.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtha.2024.06.008","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T19:39:09Z","timestamp":1719257949000},"page":"2773-2783","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0639-8542","authenticated-orcid":false,"given":"Bernhard","family":"Nagler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Staudinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Schellongowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Knoebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kornfehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schwameis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Herkner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Buchtele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.06.008_bib1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/s00134-016-4314-7","article-title":"Venovenous extracorporeal membrane oxygenation for acute respiratory failure: a clinical review from an international group of experts","volume":"42","author":"Fan","year":"2016","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1002\/ehf2.13202","article-title":"Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock","volume":"8","author":"Schrage","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jtha.2024.06.008_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13054-024-04901-7","article-title":"Effect of intra-arrest transport, extracorporeal cardiopulmonary resuscitation and immediate invasive assessment in refractory out-of-hospital cardiac arrest: a long-term follow-up of the Prague OHCA trial","volume":"28","author":"Rob","year":"2024","journal-title":"Crit Care"},{"key":"10.1016\/j.jtha.2024.06.008_bib4","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s00134-022-06723-z","article-title":"How to manage anticoagulation during extracorporeal membrane oxygenation","volume":"48","author":"Levy","year":"2022","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib5","first-page":"535","article-title":"Optimizing anticoagulation for venovenous ECMO: finding the right balance","volume":"209","author":"Meuwese","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib6","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1164\/rccm.202305-0896OC","article-title":"Anticoagulation and bleeding during veno-venous extracorporeal membrane oxygenation: insights from the PROTECMO Study","volume":"209","author":"Martucci","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib7","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMra2104091","article-title":"Heparin resistance - clinical perspectives and management strategies","volume":"385","author":"Levy","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib8","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jtha.2023.10.030","article-title":"\"Defining Heparin Resistance: Communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis\": comment from Gouin-Thibault et\u00a0al","volume":"22","author":"Gouin-Thibault","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.008_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","article-title":"An overview of the antimicrobial resistance mechanisms of bacteria","volume":"4","author":"Reygaert","year":"2018","journal-title":"AIMS Microbiol"},{"key":"10.1016\/j.jtha.2024.06.008_bib10","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1016\/j.jtha.2023.08.013","article-title":"Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis","volume":"21","author":"Levy","year":"2023","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.008_bib11","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00134-023-07103-x","article-title":"Resistance to unfractionated heparin in the ICU: evaluation and management options","volume":"49","author":"Levy","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.1994.00420010073009","article-title":"A\u00a0randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin","volume":"154","author":"Levine","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib13","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/jth.15464","article-title":"Heparin - messias or verschlimmbesserung?","volume":"19","author":"Swan","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.008_bib14","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11239-021-02615-z","article-title":"Evaluation of heparin infusion rates in patients with intravenous drug misuse","volume":"53","author":"Barga","year":"2022","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.06.008_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-020-02145-0","article-title":"Heparin resistance in COVID-19 patients in the intensive care unit","volume":"50","author":"White","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2024.06.008_bib16","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/ijlh.13543","article-title":"Heparin dosage, level, and resistance in SARS-CoV2 infected patients in intensive care unit","volume":"43","author":"Novelli","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2024.06.008_bib17","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/MAT.0000000000001334","article-title":"Heparin resistance is common in patients undergoing extracorporeal membrane oxygenation but is not associated with worse clinical outcomes","volume":"67","author":"Raghunathan","year":"2021","journal-title":"ASAIO J"},{"key":"10.1016\/j.jtha.2024.06.008_bib18","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1097\/CCM.0000000000004590","article-title":"A\u00a0randomized controlled trial of antithrombin supplementation during extracorporeal membrane oxygenation","volume":"48","author":"Panigada","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib19","doi-asserted-by":"crossref","first-page":"e365","DOI":"10.1055\/s-0040-1719083","article-title":"Monitoring of unfractionated heparin in severe COVID-19: an observational study of patients on CRRT and ECMO","volume":"4","author":"Streng","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.jtha.2024.06.008_bib20","article-title":"Argatroban for anticoagulation in patients requiring venovenous extracorporeal membrane oxygenation in coronavirus disease 2019","volume":"3","author":"Sattler","year":"2021","journal-title":"Crit Care Explor"},{"key":"10.1016\/j.jtha.2024.06.008_bib21","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1378\/chest.108.3.767","article-title":"RBC transfusion in the ICU. Is there a reason?","volume":"108","author":"Corwin","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.06.008_bib22","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1001\/jama.288.12.1499","article-title":"Anemia and blood transfusion in critically ill patients","volume":"288","author":"Vincent","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.06.008_bib23","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.008_bib24","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/jth.14975","article-title":"Coagulopathy in COVID-19","volume":"18","author":"Iba","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.008_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102196","article-title":"Heparin monitoring during extracorporeal membrane oxygenation: the effect of dextran sulfate on anti-Xa assay","volume":"7","author":"Hammami","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.06.008_bib26","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1161\/01.ATV.17.8.1568","article-title":"Induction of the acute-phase reaction increases heparin-binding proteins in plasma","volume":"17","author":"Young","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jtha.2024.06.008_bib27","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/ALN.0000000000004920","article-title":"Antithrombin levels and heparin responsiveness during veno-arterial extracorporeal membrane oxygenation: a prospective single-center cohort study","volume":"140","author":"Mansour","year":"2024","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2024.06.008_bib28","first-page":"85","article-title":"Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in\u00a0vitro","volume":"26","author":"Krulder","year":"1996","journal-title":"Haemostasis"},{"key":"10.1016\/j.jtha.2024.06.008_bib29","first-page":"963","article-title":"A\u00a0prospective pilot trial to assess the efficacy of argatroban (Argatra\u00ae) in critically ill patients with heparin resistance","volume":"9","author":"Bachler","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-0034-1398382","article-title":"Efficacy of argatroban in critically ill patients with heparin resistance: a retrospective analysis","volume":"41","author":"Treichl","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.06.008_bib31","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/CCM.0000000000005033","article-title":"Comparison of bivalirudin versus heparin for maintenance systemic anticoagulation during adult and pediatric extracorporeal membrane oxygenation","volume":"49","author":"Seelhammer","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jtha.2024.06.008_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/MAT.0000000000002085","article-title":"Prevalence of FXII-deficiency and its relevance to monitoring anticoagulation in adults receiving extracorporeal membrane oxygenation","volume":"70","author":"Brock","year":"2024","journal-title":"ASAIO J"},{"key":"10.1016\/j.jtha.2024.06.008_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/10760296231207062","article-title":"Prevalence and impact of lupus anticoagulant in patients receiving extracorporeal membrane oxygenation","volume":"29","author":"Kornfehl","year":"2023","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2024.06.008_bib34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jtha.2022.11.014","volume":"21","author":"Helms","year":"2023","journal-title":"J\u00a0Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T20:45:43Z","timestamp":1759351543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1538783624003659"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.008","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of heparin resistance and heparin failure in patients receiving extracorporeal membrane oxygenation: an exploratory retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}